Impact of race/ethnicity and gender on HCV screening and prevalence among US veterans in department of veterans affairs care

American Journal of Public Health

Volumn 104, Issue SUPPL. 4, 2014, Pages

  Backus, Lisa I ^a,b   Belperio, Pamela S ^a,c   Loomis, Timothy P ^a   Mole, Larry A ^a  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ANCESTRY GROUP; ARTICLE; ETHNIC GROUP; ETHNOLOGY; FEMALE; GOVERNMENT; HEPATITIS C; HUMAN; MALE; MASS SCREENING; PREVALENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICS; UNITED STATES; VETERAN; VETERANS HEALTH;

AGE FACTORS; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HEPATITIS C; HUMANS; MALE; MASS SCREENING; PREVALENCE; RETROSPECTIVE STUDIES; SEX FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS; VETERANS HEALTH;

EID: 84906074374     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2014.302090     Document Type: Article

References (22)

1. Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61(RR-4):1-32.
2. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705-714.
3. Roblin DW, Smith BD, Weinbaum CM, Sabin ME. HCV screening practices and prevalence in an MCO, 2000-2007. Am J Manag Care. 2011;17(8):548-555.
4. Spradling PR, Rupp L, Moorman AC, et al. Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence. Clin Infect Dis. 2012;55(8):1047-1055.
5. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156(4):271-278.
6. Rein DB, Wittenborn JS, Weinbaum CM, Sabin M, Smith BD, Lesesne SB. Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. Dig Liver Dis. 2011;43(1):66-72.
7. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341(8): 556-562.
8. Rein DB, Smith BD, Wittenborn JS, et al. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med. 2012;156(4):263-270.
9. Forde KA, Tanapanpanit O, Reddy KR. Hepatitis B and C in African Americans: current status and continued challenges. Clin Gastroenterol and Hepatol. 2014;12(5): 738-748.
10. Seeff LB, Miller RN, Rabkin CS, et al. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med. 2000;132(2):105-111.
11. Dominitz JA, Boyko EJ, Koepsell TD, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology. 2005;41(1): 88-96.
12. Backus LI, Belperio PS, Loomis TP, Yip GH, Mole LA. Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs care. JAMA Intern Med. 2013;173(16):1549-1552.
13. Pyrsopoulos N, Jeffers L. Hepatitis C in African Americans. J Clin Gastroenterol. 2007;41(2):185-193.
14. Butterfield MI, Bosworth HB, Stechuchak KM, et al. Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans with severe mental illness. J Natl Med Assoc. 2004;96(1):43-52.
15. Liu S, Cipriano LE, Holodniy M, Goldhaber-Fiebert JD. Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States. PLoS ONE. 2013;8(3):e58975.
16. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17(2):107-115.
17. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: World Health Organization; 1980.
18. Ditah I, Ditah F, Devaki P, et al. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. J Hepatol. 2014;60(4):691-698.
19. Southern WN, Drainoni ML, Smith BD, et al. Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting. J Viral Hepat. 2011; 18(7):474-481.
20. Lawitz E, Mangia A, Wyles D, et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med. 2013;368(20):1878-1887.
21. Fleckenstein J. Chronic hepatitis C in African Americans and other minority groups. Curr Gastroenterol Rep. 2004;6(1):66-70.
22. Institute of Medicine. Hepatitis and liver cancer: a national strategy for the prevention and control of hepatitis B and C. 2010. Available at: http://www.iom. edu/Reports/2010/Hepatitis-and-Liver-Cancer-ANational-Strategy- for-Prevention-and-Control-of-Hepatitis-B-and-C.aspx. Accessed May 1, 2014.